AbCellera Biologics Inc. (NASDAQ:ABCL) is highlighted as one of the best healthcare stocks under $30, specializing in therapeutic antibodies for various diseases. The company recently started a Phase 1 clinical trial for ABCL635 targeting menopause symptoms, showing strong Q2 revenue growth. Analysts suggest ABCL could be a top biotech stock to watch.

Read more at Yahoo Finance: AbCellera Biologics (ABCL) Advances Proprietary Pipeline with Promising Phase 1 Trial Results